LOS ANGELES, Sept. 20, 2022 (GLOBE NEWSWIRE) — The latest research report titled “Global Oral Antidiabetic Drugs Market Analysis and Forecast” has been added to the extensive database of Data Bridge Market Research. This comprehensive report spans 350 pages and includes 220 tables and 60 figures, which detail the top companies in the sector. The Oral Antidiabetic Drugs report presents a wealth of market insights aimed at enhancing your understanding of the current market landscape, identifying potential challenges for the industry, and offering strategies for optimal brand positioning. It assesses market potential by geographical region, taking into account growth rates, macroeconomic factors, consumer preferences, and trends in demand and supply dynamics. To improve user engagement, the report meticulously represents statistical and numerical data through well-organized tables and figures.

Data Bridge Market Research conducts a thorough analysis of the growth trajectory in the global oral antidiabetic drugs market during the forecast period from 2022 to 2029. The anticipated CAGR of approximately 3% is projected for the global oral antidiabetic drugs market throughout this timeline. Valued at USD 45 billion in 2021, the market is forecasted to expand to USD 57 billion by 2029. Beyond fundamental market insights—including value, growth rate, segmentation, geographical coverage, competitive landscape, and scenario analysis—this report, curated by the Data Bridge Market Research team, also features in-depth evaluations of patient epidemiology, drug pipelines, pricing structures, and pertinent regulatory frameworks.

Download a Sample Report to Explore the Full Insights @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-oral-antidiabetic-drugs-market

Comprehensive Market Insights:

Diabetes is characterized by elevated glucose levels in the bloodstream due to insufficient insulin production in the body. Antidiabetic drugs are utilized to manage this condition effectively. These medications work by reducing blood glucose levels through the activation of glycogen phosphorylase and gluconeogenic enzymes, leading to decreased glycogenolysis and gluconeogenesis rates. The significance of these medications in the healthcare sector is profound, and their demand is expected to surge during the forecast period as awareness about diabetes management increases.

The global oral antidiabetic drugs market is set to experience remarkable growth in the upcoming years. This surge is primarily driven by the rising prevalence of type 2 diabetes, spurred on by lifestyle changes, environmental factors, and genetic predispositions. The impact of unhealthy diets and pollution cannot be overlooked, as they contribute substantially to this upward trend. Moreover, many leading pharmaceutical companies are actively engaged in innovative drug discovery and development, which is further bolstered by the market shifts induced by the COVID-19 pandemic, affecting both production and consumption patterns.

Key Metrics of the Report

• Forecast Period – 2022 to 2029

• Historic Years – 2020 (Customizable to 2014 – 2019)

Leading Players in the Global Oral Antidiabetic Drugs Market:

• Pfizer Inc (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Mylan N.V. (U.S.)
• Fresenius Kabi AG (Germany)
• Novartis AG (Switzerland)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Bristol Myers Squibb Company (U.S.)
• GSK Plc. (U.S.)
• Bayer AG (Germany)

Emerging Opportunities in the Market

• Increased Demand for Retail Pharmacies

The growing number of retail pharmacies providing open-angle glaucoma therapeutics signifies a burgeoning opportunity for market expansion. Furthermore, the rise in retail pharmacies across developed nations enhances accessibility for patients seeking medications. Retail pharmacies have become the preferred choice for many patients due to their convenience and ease of access.

• Soaring Demand for Metformin

Among all oral antidiabetic medications, metformin remains the most widely prescribed treatment globally, accounting for 45–50% of all prescriptions and being utilized by over 150 million individuals annually. Its long-term benefits, coupled with strong clinical evidence supporting its efficacy and safety, make metformin a cornerstone in diabetes management. The drug’s affordability and high adherence rates further contribute to its popularity, paving the way for significant market growth.

Access the Complete 350 Pages PDF Research Report @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-oral-antidiabetic-drugs-market

This report elucidates the following key aspects:

1. Market Penetration: Comprehensive insights into the product offerings of leading players in the oral antidiabetic drugs market.
2. Product Development/Innovation: Detailed analysis of emerging technologies, ongoing R&D efforts, and anticipated product launches.
3. Competitive Assessment: In-depth evaluation of market strategies, geographical segments, and business models of key players.
4. Market Development: Comprehensive insights into emerging markets, with an analysis of various segments across different geographies.
5. Market Diversification: Detailed information on new products, untapped regions, recent developments, and investments in the oral antidiabetic drugs market

Leading Industry Drivers Fueling Growth:

• Increasing Incidence of Diabetes

The global population of adults with diabetes reached approximately 537 million in 2021, with projections indicating an increase to 643 million by 2030. Key factors contributing to this surge include rising obesity rates, unhealthy dietary habits, and inadequate physical activity. As a result, the growing number of newly diagnosed cases of Type 1 and Type 2 diabetes significantly accelerates market growth.

Identifying Restraints and Challenges

• Side Effects of Oral Antidiabetic Drugs

The use of oral antidiabetic drugs is often associated with various side effects, including nausea, gas, bloating, diarrhea, vitamin B12 deficiency, and gastrointestinal discomfort. These adverse effects can hinder patient adherence and affect overall market growth.

Additionally, the high costs associated with treatment options present a significant challenge, limiting accessibility for many patients and further impeding market expansion.

This comprehensive global oral antidiabetic drugs market report encompasses recent developments, trade regulations, import-export analyses, production assessments, value chain optimization, market share evaluations, the influence of domestic and localized market players, opportunities for emerging revenue streams, regulatory changes, strategic growth analyses, market sizing, category growth assessments, niche applications, product approvals, product launches, geographic expansion strategies, and technological innovations within the market. For additional insights regarding the global oral antidiabetic drugs market, please contact Data Bridge Market Research for an Analyst Brief, where our team is ready to assist you in making informed decisions for market growth.

Stay Updated with the Latest Market Study Edition @ https://www.databridgemarketresearch.com/reports/global-oral-antidiabetic-drugs-market

Key Market Segmentation in the Oral Antidiabetic Drugs Market

The global oral antidiabetic drugs market is segmented by drug class, distribution channels, and end-users. Analyzing growth within these segments allows for a clearer understanding of niche growth areas and provides valuable insights for making strategic decisions on core market applications.

Drug Class Segmentation

• Biguanides
• Thiazolidinediones
• Dipeptidyl Peptidase IV Inhibitors, α-Glucosidase Inhibitors
• Insulin Secretagogues
• Amylin Analog
• Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors
• Glucagon-Like Peptide-1 Receptor Agonists

End-User Segmentation

• Hospitals
• Homecare Settings
• Specialty Clinics

Distribution Channel Segmentation

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Regional Insights and Analysis of the Oral Antidiabetic Drugs Market

Key regions included in the global oral antidiabetic drugs market report include the U.S., Canada, and Mexico in North America; Germany, France, the U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and the rest of Europe; China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, and the Philippines in the Asia-Pacific (APAC); and Saudi Arabia, the U.A.E, South Africa, Egypt, Israel, and the rest of the Middle East and Africa (MEA), as well as Brazil, Argentina, and the rest of South America.

North America is projected to experience the highest market growth due to a rapidly increasing population affected by smoking and obesity, alongside the presence of leading manufacturers. Meanwhile, the Asia-Pacific region dominates the market due to a higher prevalence of diabetes and related disorders, as well as a growing number of generic drug options.

Detailed Table of Contents

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers and Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

For Further Insights, Access the Comprehensive TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-oral-antidiabetic-drugs-market

Explore More Reports:

• Antidiabetic Combinations Market, by Drug Class (Thiazolidinedione and Sulfonylurea Combination, Thiazolidinedione and Biguanide Combination, and Others), Route of Administration (Oral, Injections, and Others), End-Users (Hospitals, Specialty Clinics, and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-antidiabetic-combinations-market

• Oral Care Products & Other Dental Consumables Market, by Product (Dental Restoration Products, Dental Implants, Dental Prosthetics, Dental Bridges, Dental Restoration Materials, Indirect Restorative Materials, Dental Biomaterials, Direct Restorative Materials, Orthodontics, Periodontics, Infection Control, Endodontics, Whitening Products, Finishing & Polishing Products), Distribution Channel (Consumer Stores, Dental Dispensaries, Retail Pharmacies, Online Distribution), Geography (North America, South America, Europe, Asia-Pacific, Middle East, and Africa) https://www.databridgemarketresearch.com/reports/global-oral-care-products-other-dental-consumables-market

• Oral Care/Oral Hygiene Market, by Product (Toothpastes, Toothbrushes and Accessories, Mouthwashes/Rinses, Dental Accessories/Ancillaries, Denture Products, Dental Prosthesis Cleaning Solutions), Distribution Channel (Consumer Stores, Retail Pharmacies, Online Distribution, Dental Dispensaries, Drug Store), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-oral-careoral-hygiene-market

• Oral Drug Delivery Market, by Type (Controlled Release, Orodispersible Tablets, Taste Making), Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, Other Applications), End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, Diagnostic Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-oral-drug-delivery-market

• <u>Oral Care Oral Hygiene Products Market</u>, by Product (Toothpastes, Toothbrushes and Accessories, Mouthwashes/Rinses, Dental Accessories/Ancillaries, Denture Products, Dental Prosthesis Cleaning Solutions), Distribution Channel (Consumer Stores, Retail Pharmacies, Online Distribution, Dental Dispensaries, Drug Store) https://www.databridgemarketresearch.com/reports/global-oral-care-oral-hygiene-products-market

• Oral Cancer Treatment Market, by Type (Oral Squamous Cell Carcinoma, Oral Verrucous Carcinoma, Mucoepidermoid Carcinoma, and Oral Cavity Lymphomas), Therapy Type (Chemotherapy, Radiation Therapy, and Biological Therapy), Treatment (Medication and Surgery), Route of Administration (Oral, Injectable, and Others), End Users (Hospitals, Homecare, Specialty Clinics, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-oral-cancer-treatment-market

• Oral Electrolyte Solutions Market, by Type (Orange, Lemonade, Others), Indication (Diarrhea, Vomiting, Others), Application (Infants, Children, Adults), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) https://www.databridgemarketresearch.com/reports/global-oral-electrolyte-solutions-market

About Data Bridge Market Research:

Understanding Current Trends is Essential for Future Forecasting!

Data Bridge Market Research presents itself as a cutting-edge market research and consulting firm, demonstrating unparalleled resilience and integrated methodologies. Our commitment is to identify the best market opportunities and provide relevant insights to empower your business to thrive in a competitive landscape. We are dedicated to delivering suitable solutions to complex business challenges, fostering a seamless decision-making process. Founded in 2015 in Pune, Data Bridge Market Research emerges from a wealth of wisdom and experience.

With over 500 analysts across various industries, Data Bridge Market Research has served more than 40% of the Fortune 500 companies globally and boasts a clientele of over 5000 satisfied customers around the world. Our dedication to client satisfaction is reflected in our impressive 99.9% satisfaction rate.

Contact Us:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: [email protected]